BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease
February 08, 2017 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 08, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease
January 09, 2017 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Jan. 09, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease
September 12, 2016 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 12, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course
July 13, 2016 10:46 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 13, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
June 28, 2016 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., June 28, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference
May 31, 2016 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., May 31, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders
May 23, 2016 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., May 23, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or "the Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Deepens Board of Directors With Addition of Robert B. Catell, Former Chairman and CEO of KeySpan Corporation and Chairman of National Grid, US
February 23, 2016 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 23, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic Product
February 09, 2016 08:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 09, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
BioRestorative Therapies Provides Company Updates With Shareholder Letter
December 21, 2015 08:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 21, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced the...